Table 1.
p16/Ki-67, p16/mcm2, LBC and HPV16/18 positivity with baseline histology categories, N (%)
| Category | p16/Ki-67 | p16/mcm2 | LBC (≥ASC-US) | HPV16/18 genotyping |
|---|---|---|---|---|
| Normal | 34 (19.5) | 55 (31.6) | 13 (7.5) | 5 (2.9) |
| CIN1 | 2 (28.6) | 5 (71.4) | 2 (28.6) | 3 (42.9) |
| CIN2 | 3 (100.0) | 3 (100.0) | 0 (0.0) | 0 (0.0) |
| CIN3 | 11 (91.7) | 10 (83.3) | 7 (58.3) | 4 (33.3) |
| Cancer | 2 (100.0) | 2 (100.0) | 1 (50.0) | 1 (50.0) |
| Total | 52 (26.3) | 75 (37.9) | 23 (11.6) | 13 (6.6) |
Abbreviations: CIN, cervical intraepithelial neoplasia; CIN2+, cervical intraepithelial neoplasia grade 2 or worse; CIN3+, cervical intraepithelial neoplasia grade 3 or worse; LBC, liquid-based cytology.